Benzinga's Top Downgrades - CME Gr (NASDAQ:CME), Adicet Bio (NASDAQ:ACET)

Morgan Stanley downgraded U.S. Bancorp USB from Equal-Weight to Underweight. U.S. Bancorp shares fell 0.06 percent to $47.87 in pre-market trading.
Analysts at Citigroup downgraded SeaWorld Entertainment Inc SEAS from Buy to Neutral. The price target for SeaWorld has been raised from $14 to $17. SeaWorld shares fell 1.47 percent to $16.75 in pre-market trading.
First Analysis downgraded Aceto Corporation ACET from Overweight to Equal-Weight. Aceto shares rose 1.07 percent to close at $18.84 on Friday.
Stifel Nicolaus downgraded Capital One Financial Corp. COF from Buy to Hold. The price target for Capital One has been raised from $76 to $84. Capital One shares rose 2.22 percent to close at $80.99 on Friday.
Analysts at Citigroup downgraded Ultragenyx Pharmaceutical Inc RARE from Neutral to Sell. The price target for Ultragenyx Pharmaceutical has been lowered from $66 to $64. Ultragenyx Pharmaceutical shares dropped 2.02 percent to $80.40 in pre-market trading.
Brean Capital downgraded Viacom, Inc. VIAB from Buy to Hold. Viacom shares rose 1.08 percent to close at $ 38.42 on Friday.
Berenberg downgraded Nucor Corporation NUE from Buy to Hold. Nucor shares rose 0.68 percent to $59.15 in pre-market trading.
Analysts at JP Morgan downgraded CME Group Inc CME from Overweight to Neutral. CME shares fell 0.57 percent to $113.73 in pre-market trading.
Baird downgraded Williams-Sonoma, Inc. WSM from Outperform to Neutral. Williams-Sonoma shares gained 1.28 percent to close at $52.12 on Friday.
Analysts at Deutsche Bank downgraded Werner Enterprises, Inc. WERN from Buy to Hold. Werner Enterprises shares rose 0.77 percent to close at $26.10 on Friday.

Market News and Data brought to you by Benzinga APIs